艾博生物成立于2019年1月，是一家专注于信使核糖核酸（mRNA）药物研发的临床期创新型生物医药公司，拥有业界领先并具有自主知识产权的mRNA和纳米递送技术平台。 公司已建立了丰富的产品管 …

Feb 8, 2026 · Abogen Biosciences is a series C company based in Suzhou (China), founded in 2019 by Ying Bo and Dr InBev. It operates as a Developer of mRNA-based therapeutics for cancer and …

Sep 3, 2025 · Last year, Abogen received a massive amount of funding as it was moving the candidate forward. However, while the candidate is moving forward overseas, it’s still finding itself stuck in …

Dec 23, 2021 · China’s Abogen advancing mRNA vaccine for COVID-19, pipeline with $700M series C Record-setting round, crossover investors and new CFO could position Abogen for a listing

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Abogen Biosciences is a fully integrated new powerhouse in the evolving field of mRNA-based therapeutics. Driven by the mission to revolutionize the future of health and life, we are committed...

Find company research, competitor information, contact details & financial data for Suzhou Abogen Biosciences Co., Ltd. of Suzhou, Jiangsu. Get the latest business insights from Dun & Bradstreet.